Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | EDNRA | P25101 | 9/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | NSD2 | O96028 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | F2 | P00734 | 2/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30362953 | 0.82 | CA2 (0.69) | CA2EDNRACYP1A2CYP2C19HTT | |
| SCHEMBL21283 | 0.82 | CA2 (0.69) | CA2EDNRACYP1A2CYP2C19HTT | |
| SCHEMBL10344363 | 0.82 | CA2 (0.69) | CA2EDNRACYP1A2CYP2C19HTT | |
| SCHEMBL29429225 | 0.82 | CA2 (0.69) | CA2EDNRACYP1A2CYP2C19HTT | |
| SCHEMBL31040675 | 0.80 | CA2 (0.67) | CA2EDNRACYP1A2CYP2C19HTT | |
| Hydrochloric Acid SCHEMBL27789615 | 0.80 | CA2 (0.67) | CA2EDNRACYP1A2CYP2C19HTT | |
| SCHEMBL28444883 | 0.80 | CA2 (0.67) | CA2EDNRACYP1A2CYP2C19HTT | |
| SCHEMBL6896169 | 0.80 | CA2 (0.58) | CA2EDNRACYP1A2CYP2C19HTT | |
| Bicarbonate SCHEMBL28267246 | 0.79 | CA2 (0.61) | CA2EDNRACYP1A2CYP2C19HTT | |
| SCHEMBL27083185 | 0.78 | CA2 (0.47) | CA2EDNRACYP1A2CYP2C19HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3013787-B1 | TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES | COUNCIL SCIENT IND RES (IN) | 2017-08-02 | — | — | EP | disclosed |
| EP-3013787-B1 | TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES | COUNCIL SCIENT IND RES (IN) | 2017-08-02 | — | — | EP | disclosed |
| US-9650329-B2 | Transition-metal-free N-arylation of tertiary amines using arynes | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2017-05-16 | — | — | US | disclosed |
| US-9650329-B2 | Transition-metal-free N-arylation of tertiary amines using arynes | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2017-05-16 | — | — | US | disclosed |
| US-20160137587-A1 | TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2016-05-19 | — | — | US | disclosed |
| US-20160137587-A1 | TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2016-05-19 | — | — | US | disclosed |
| EP-3013787-A1 | TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES | Council of Scientific & Industrial Research (IN) | 2016-05-04 | — | — | EP | disclosed |
| WO-2014207761-A1 | TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160137587-A1 | TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES | CDK6, NEK6, MCM6 | CA2 3598/4885EDNRA 2199/4885CYP1A2 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.